X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-01-30 | CANO | Cooperstone Elliot | 10% | S - Sale | $2.65 | -22,738 | 516,155 | -4% | -$60,243 | |||||
| M | 2024-01-25 | CANO | Cooperstone Elliot | 10% | S - Sale | $2.71 | -92,619 | 538,893 | -15% | -$251,167 | |||||
| M | 2024-01-22 | CANO | Cooperstone Elliot | 10% | S - Sale | $2.69 | -233,842 | 631,512 | -27% | -$629,175 | |||||
| M | 2024-01-17 | CANO | Cooperstone Elliot | 10% | S - Sale | $2.11 | -200,000 | 865,354 | -19% | -$422,797 | |||||
| DM | 2024-01-10 | CANO | Cooperstone Elliot | 10% | S - Sale+OE | $3.55 | -74,171 | 1,065,354 | -7% | -$262,960 | |||||
| M | 2024-01-05 | CANO | Cooperstone Elliot | 10% | S - Sale | $3.81 | -75,000 | 74,319 | -50% | -$285,458 | |||||
| M | 2024-01-02 | CANO | Cooperstone Elliot | 10% | S - Sale | $4.67 | -131,833 | 149,319 | -47% | -$615,629 | |||||
| M | 2023-12-27 | CANO | Cooperstone Elliot | 10% | S - Sale | $5.88 | -113,916 | 281,152 | -29% | -$670,242 | |||||
| M | 2023-12-21 | CANO | Cooperstone Elliot | 10% | S - Sale | $5.67 | -137,683 | 395,068 | -26% | -$781,106 | |||||
2023-08-11 | CANO | Camerlinck Robert | COO | S - Sale | $0.77 | -30,646 | 26,958,642 | 0% | -$23,453 | ||||||
| M | 2023-06-28 | CANO | Aguilar Richard | Chief Clinical Officer | S - Sale | $1.29 | -550,000 | 1,213,984 | -31% | -$709,060 | |||||
| DM | 2023-06-07 | CANO | Aguilar Richard | Chief Clinical Officer | S - Sale+OE | $1.36 | -1,275,940 | 1,213,984 | -51% | -$1,733,966 | |||||
2023-06-06 | CANO | Armstrong David J | See remarks | S - Sale | $1.38 | -3,163 | 656,626 | 0% | -$4,351 | ||||||
2023-04-05 | CANO | Koppy Brian D | CFO | S - Sale | $1.27 | -23,591 | 802,570 | -3% | -$30,067 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |